CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025

Jun 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-05-30

Reporting Person: Daly Richard J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-30	Common stock, par value $0.001 per share	S	70000	$24.86	Acquired	199764	Direct

Footnotes

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in a range between $24.75 and $25.00 per share.